Nuvation Bio Inc. Class A Common Stock vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.71B), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $38.55 (market cap $339.46M). The key difference: Nuvation Bio Inc. Class A Common Stock is far larger — about 5× Roundhill S&P 500 0DTE Covered Call Strategy ETF's market cap, and Roundhill S&P 500 0DTE Covered Call Strategy ETF is more actively traded (214,614 versus 5,448,712). Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and Roundhill S&P 500 0DTE Covered Call Strategy ETF for 54 Days on average.
| NUVB | XDTE | |
|---|---|---|
Market Cap | $1.71B | $339.46M |
Volume | 5,448,712 | 214,614 |
Sector | Health | Income / Options Overlay |
52-Week High | $9.54 | $44.76 |
52-Week Low | $3.41 | $36.00 |
Typical Hold Time | 0 Days | 54 Days |
Enterprise Value | $1.30B | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →